ALKBH5 regulates the content of lactic acid and accumulation of tumor immune cells in the tumor microenvironment, so that ALKBH5 might serve as a potential therapeutic target to enhance the effect of immunotherapy in melanoma, colorectal, and potentially other cancer types [34]. The gene discussed is ALKBH5; the disease is neoplasm.